Liberty One Investment Management LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,248 shares of the healthcare conglomerate's stock after acquiring an additional 551 shares during the period. Liberty One Investment Management LLC's holdings in UnitedHealth Group were worth $4,172,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. Pacer Advisors Inc. grew its stake in UnitedHealth Group by 5.7% during the 2nd quarter. Pacer Advisors Inc. now owns 65,860 shares of the healthcare conglomerate's stock worth $33,540,000 after purchasing an additional 3,525 shares in the last quarter. Garden State Investment Advisory Services LLC increased its stake in shares of UnitedHealth Group by 13.5% during the second quarter. Garden State Investment Advisory Services LLC now owns 1,049 shares of the healthcare conglomerate's stock worth $536,000 after buying an additional 125 shares during the period. Columbus Hill Capital Management L.P. acquired a new position in UnitedHealth Group during the 2nd quarter worth approximately $14,789,000. Summit Trail Advisors LLC lifted its position in shares of UnitedHealth Group by 33.3% during the 2nd quarter. Summit Trail Advisors LLC now owns 12,008 shares of the healthcare conglomerate's stock worth $6,115,000 after purchasing an additional 2,999 shares during the last quarter. Finally, Transatlantique Private Wealth LLC raised its stake in UnitedHealth Group by 9.9% in the second quarter. Transatlantique Private Wealth LLC now owns 2,594 shares of the healthcare conglomerate's stock valued at $1,291,000 after buying an additional 234 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.
Analyst Ratings Changes
Several brokerages have recently weighed in on UNH. UBS Group cut their target price on UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. KeyCorp restated an "overweight" rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday. Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research report on Tuesday, December 3rd. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Finally, Oppenheimer lifted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $627.74.
View Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Price Performance
NYSE:UNH traded down $0.56 during trading hours on Monday, reaching $510.03. 7,462,712 shares of the company traded hands, compared to its average volume of 5,104,531. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm's 50-day moving average is $549.37 and its 200-day moving average is $563.70. The stock has a market cap of $469.37 billion, a P/E ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm posted $5.83 earnings per share. The company's quarterly revenue was up 6.8% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group's dividend payout ratio is currently 54.72%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.